Selenium Gluconate

Selenium gluconate is an organic selenium compound in which selenium is bound to gluconic acid, designed to enhance bioavailability and gastrointestinal tolerability compared to inorganic selenium salts. Once absorbed, it is metabolized into selenocysteine and selenomethionine, which are incorporated into selenoproteins including glutathione peroxidase and thioredoxin reductase to support antioxidant defense.

Origin & History

Selenium gluconate is a chelated mineral compound formed by reacting gluconic acid (derived from glucose oxidation from plant or microbial sources like corn or fungi) with selenium-containing materials such as selenium dioxide or elemental selenium. The extraction involves an aqueous reaction at 40-80°C for 0.5-2 hours at pH 3-7, using a molar ratio of gluconic acid to selenium of 2:1 to 5:1.

Historical & Cultural Context

No historical or traditional medicinal uses of selenium gluconate are documented. It appears to be a modern synthetic compound without ties to traditional medicine systems.

Health Benefits

• No clinical evidence available - selenium gluconate lacks specific human trials
• General selenium benefits may apply - supports selenoprotein synthesis and antioxidant enzyme function (no direct evidence for gluconate form)
• Theoretical antioxidant support - selenium is metabolized to support glutathione peroxidase (mechanism established for selenium, not specifically gluconate)
• Potential bioavailability advantages - chelated forms may enhance absorption over inorganic selenium (theoretical, not clinically proven for gluconate)
• Research gap identified - no RCTs, meta-analyses, or clinical trials exist for this specific form

How It Works

Selenium gluconate is hydrolyzed post-absorption, releasing selenium that is converted via the transsulfuration pathway into selenocysteine, the active form incorporated into the UGA codon-encoded selenoproteins. These include glutathione peroxidase (GPx1–GPx4), which reduces hydrogen peroxide and lipid hydroperoxides, and thioredoxin reductase (TrxR), which regenerates thioredoxin to maintain cellular redox balance. Additionally, selenoprotein P serves as the primary selenium transport protein in plasma, distributing selenium to peripheral tissues including the brain and testes.

Scientific Research

No clinical trials, RCTs, or meta-analyses specifically on selenium gluconate were identified in the available research. While general selenium studies exist for other forms like elemental selenium or selenomethionine, none reference the gluconate form or provide PMIDs for this specific compound.

Clinical Summary

No published randomized controlled trials have specifically evaluated selenium gluconate in human subjects, representing a critical gap in the evidence base for this particular selenium form. General selenium supplementation research using selenomethionine and sodium selenite—such as the Nutritional Prevention of Cancer (NPC) trial (n=1,312) and SELECT trial (n=35,533)—provides indirect mechanistic context but cannot be extrapolated to confirm equivalent outcomes for the gluconate form. Animal pharmacokinetic studies suggest organic selenium compounds including gluconate forms may achieve higher tissue retention than inorganic selenite, but human bioavailability data for selenium gluconate specifically remains unpublished. Clinicians currently rely on general selenium RDA guidelines (55 mcg/day for adults) when recommending this form, without gluconate-specific efficacy benchmarks.

Nutritional Profile

Selenium gluconate is a mineral supplement providing elemental selenium chelated with gluconic acid. Each molecule delivers approximately 1.3–1.5% elemental selenium by weight (varies by manufacturer; a typical 200 mcg selenium dose is derived from ~13–15 mg selenium gluconate). Contains no significant macronutrients (protein, fat, carbohydrate, or fiber) at supplemental doses. The gluconic acid moiety contributes negligible caloric value. Bioavailability is considered moderate — generally regarded as intermediate between inorganic sodium selenite (~50–60% absorption) and organic selenomethionine (~90% absorption), with estimated oral absorption of approximately 50–70% in humans. Selenium from this form is incorporated into the general selenium metabolic pool, supporting synthesis of 25 known human selenoproteins including glutathione peroxidases (GPx1–GPx4), thioredoxin reductases (TrxR1–TrxR3), iodothyronine deiodinases (DIO1–DIO3), and selenoprotein P (SELENOP, the primary selenium transport protein). Unlike selenomethionine, selenium gluconate is not non-specifically incorporated into body proteins in place of methionine, meaning it is more readily directed toward functional selenoprotein synthesis rather than passive tissue storage. No additional vitamins, minerals, or bioactive compounds are present unless formulated with other ingredients. Typical supplement doses provide 50–200 mcg elemental selenium per serving (Tolerable Upper Intake Level: 400 mcg/day for adults). The gluconate carrier may offer mild gastric tolerability advantages over inorganic selenium salts.

Preparation & Dosage

No clinically studied dosage ranges for selenium gluconate are available as no human trials have been conducted on this form. Standardization details and safe dosing parameters have not been established through research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Not established - no synergistic ingredients identified due to lack of research

Safety & Interactions

Selenium gluconate is generally well tolerated at recommended dietary intake levels (55–200 mcg/day), but chronic intake exceeding 400 mcg/day—the established tolerable upper intake level (UL) set by the Institute of Medicine—risks selenosis, presenting as hair loss, nail brittleness, garlic-breath odor from dimethylselenide exhalation, and peripheral neuropathy. It may potentiate the anticoagulant effect of warfarin by modulating thioredoxin reductase-dependent pathways, and concurrent use with cisplatin may reduce chemotherapy efficacy by upregulating antioxidant defenses. Selenium supplementation should be used cautiously in individuals with hypothyroidism receiving levothyroxine, as selenium influences thyroid hormone metabolism via deiodinase selenoenzymes. Pregnant women should not exceed the UL of 400 mcg/day, as excess selenium is teratogenic in animal models, though the standard prenatal dose of 60 mcg/day is considered safe.